Market Overview:
The global polymer-based pre filled syringe market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for vaccines and monoclonal antibodies, and the growing number of hospitals, home care settings, ambulances services, retail pharmacies, and mail order pharmacies. In addition, the increasing focus on patient safety is also contributing to the growth of this market. However, factors such as high cost and limited reimbursement are restraining the growth of this market.
Product Definition:
A polymer-based pre filled syringe is a medical device used to inject medications and other solutions into the body. The syringe consists of a barrel, plunger, and needle. The barrel is made of glass or plastic, while the plunger and needle are made of metal. Polymer-based materials are used in the construction of the barrel because they are strong and can be molded into various shapes.
Vaccines:
A vaccine is a medical product primarily designed to stimulate an immune response in the body. The most common types of vaccines are those for diseases such as measles, polio, and hepatitis B. Vaccines can also be used therapeutically to stimulate the immune system in order to fight cancer or autoimmune diseases.
Monoclonal antibodies:
Monoclonal antibodies are the human body's immune system. They are created in a laboratory by extracting antibodies from one person and genetically modifying them so that they will work properly for the specific task. There are two types of methods used to create monoclonal antibody: hybrid and recombinant.
Application Insights:
Based on application, the market is segmented into hospitals, home care, ambulance service, retail pharmacies and mail order pharmacies. The hospital application segment dominated the global polymer-based pre-filled syringe market in 2017 owing to factors such as increasing prevalence of infectious diseases and an increase in government funding for the construction of healthcare facilities. In addition, favorable reimbursement policies for pharmaceutical companies are also expected to drive demand over the forecast period.
The home care application segment is expected to witness significant growth over the forecast period due to factors such as rising geriatric population across countries (elderly people are more prone to various infections), increasing number of chronic diseases and high unmet medical needs pertaining specific products for treating these conditions. For instance; currently there is no vaccine available against hepatitis A & B or any other type of hepatitis but with new product developments it will become easier for consumers get access vaccines through their local pharmacist thereby driving demand globally over next eight years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D investments by major companies and rising adoption of advanced technologies across this region. Moreover, high prevalence of chronic diseases requiring regular medication has led to an increase in demand for pre-filled syringes, thereby boosting the regional market growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure.
Growth Factors:
- Increasing demand for biologics and monoclonal antibodies: The global market for biologics is expected to reach 5 billion by 2020. This is due to the increasing prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders. The use of polymers in prefilled syringes helps to maintain the stability of these drugs during storage and transport.
- Technological advancements: Polymer-based prefilled syringes are becoming increasingly popular due to their superior performance characteristics compared to traditional glass syringes. They are less likely to break or crack, which can lead to contamination or product loss. Additionally, they are easier and faster to assemble than glass syringes, making them ideal for use in high-volume manufacturing environments.
- Growing demand from emerging markets: The Asia Pacific region is expected to be the fastest-growing market for polymer-based prefilled syringes over the next five years owing to rising healthcare spending and an expanding population base that requires access medical care products and services.. In addition, many countries in this region are investing in new manufacturing facilities that will help meet the growing demand for these products..
Scope Of The Report
Report Attributes
Report Details
Report Title
Polymer-based Pre Filled Syringe Market Research Report
By Type
Vaccines, Monoclonal antibodies
By Application
Hospitals, Home care, Ambulance service, Retail pharmacies, Mail order pharmacies
By Companies
Ajinomoto Bio-Pharma, Inc., Aptar Pharma (India) Pvt. Ltd., Baxter International Inc., Biocorp, Enable Injections, Inc., Nipro Corp., SHL Medical, Shandong Weigao Group, Stevanato Group, Unilife Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Polymer-based Pre Filled Syringe Market Report Segments:
The global Polymer-based Pre Filled Syringe market is segmented on the basis of:
Types
Vaccines, Monoclonal antibodies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Home care, Ambulance service, Retail pharmacies, Mail order pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ajinomoto Bio-Pharma, Inc.
- Aptar Pharma (India) Pvt. Ltd.
- Baxter International Inc.
- Biocorp
- Enable Injections, Inc.
- Nipro Corp.
- SHL Medical
- Shandong Weigao Group
- Stevanato Group
- Unilife Corporation
Highlights of The Polymer-based Pre Filled Syringe Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vaccines
- Monoclonal antibodies
- By Application:
- Hospitals
- Home care
- Ambulance service
- Retail pharmacies
- Mail order pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polymer-based Pre Filled Syringe Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A polymer-based pre-filled syringe is a type of medication delivery device that uses a polymer to form the plunger and barrel. This type of syringe is often more durable than traditional glass or metal syringes, making it easier to handle and less likely to break. Additionally, because the polymer material does not corrode over time, these devices can remain in use for extended periods of time without needing replacement.
Some of the key players operating in the polymer-based pre filled syringe market are Ajinomoto Bio-Pharma, Inc., Aptar Pharma (India) Pvt. Ltd., Baxter International Inc., Biocorp, Enable Injections, Inc., Nipro Corp., SHL Medical, Shandong Weigao Group, Stevanato Group, Unilife Corporation.
The polymer-based pre filled syringe market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Polymer-based Pre Filled Syringe Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Polymer-based Pre Filled Syringe Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Polymer-based Pre Filled Syringe Market - Supply Chain
4.5. Global Polymer-based Pre Filled Syringe Market Forecast
4.5.1. Polymer-based Pre Filled Syringe Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Polymer-based Pre Filled Syringe Market Size (000 Units) and Y-o-Y Growth
4.5.3. Polymer-based Pre Filled Syringe Market Absolute $ Opportunity
5. Global Polymer-based Pre Filled Syringe Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Type
5.3.1. Vaccines
5.3.2. Monoclonal antibodies
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Polymer-based Pre Filled Syringe Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Home care
6.3.3. Ambulance service
6.3.4. Retail pharmacies
6.3.5. Mail order pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Polymer-based Pre Filled Syringe Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Polymer-based Pre Filled Syringe Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Polymer-based Pre Filled Syringe Demand Share Forecast, 2019-2026
9. North America Polymer-based Pre Filled Syringe Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Home care
9.4.3. Ambulance service
9.4.4. Retail pharmacies
9.4.5. Mail order pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Type
9.7.1. Vaccines
9.7.2. Monoclonal antibodies
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Polymer-based Pre Filled Syringe Demand Share Forecast, 2019-2026
10. Latin America Polymer-based Pre Filled Syringe Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Home care
10.4.3. Ambulance service
10.4.4. Retail pharmacies
10.4.5. Mail order pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Type
10.7.1. Vaccines
10.7.2. Monoclonal antibodies
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Polymer-based Pre Filled Syringe Demand Share Forecast, 2019-2026
11. Europe Polymer-based Pre Filled Syringe Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Home care
11.4.3. Ambulance service
11.4.4. Retail pharmacies
11.4.5. Mail order pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Type
11.7.1. Vaccines
11.7.2. Monoclonal antibodies
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Polymer-based Pre Filled Syringe Demand Share, 2019-2026
12. Asia Pacific Polymer-based Pre Filled Syringe Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Home care
12.4.3. Ambulance service
12.4.4. Retail pharmacies
12.4.5. Mail order pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Type
12.7.1. Vaccines
12.7.2. Monoclonal antibodies
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Polymer-based Pre Filled Syringe Demand Share, 2019-2026
13. Middle East & Africa Polymer-based Pre Filled Syringe Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Home care
13.4.3. Ambulance service
13.4.4. Retail pharmacies
13.4.5. Mail order pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Polymer-based Pre Filled Syringe Market Size and Volume Forecast by Type
13.7.1. Vaccines
13.7.2. Monoclonal antibodies
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Polymer-based Pre Filled Syringe Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Polymer-based Pre Filled Syringe Market: Market Share Analysis
14.2. Polymer-based Pre Filled Syringe Distributors and Customers
14.3. Polymer-based Pre Filled Syringe Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Ajinomoto Bio-Pharma, Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Aptar Pharma (India) Pvt. Ltd.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Baxter International Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biocorp
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Enable Injections, Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nipro Corp.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. SHL Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Shandong Weigao Group
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Stevanato Group
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Unilife Corporation
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
